Ulmus Investment logo

Ulmus Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Ulmus Investment is an investment company that aims to be a leader in its field with various investment experiences.

Investor Profile

Ulmus Investment has made 3 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Undisclosed (33%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Software
  • Analytics
  • Artificial Intelligence (Ai)
  • Health Care
  • Information Technology
  • Biopharma
  • Biotechnology
  • Life Science
  • Enterprise Software
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ulmus Investment frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
HB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
DS Investment & Securities
Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Shinyoung Securities
Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo
Co-Investments: 1
BNH Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BSK Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
HRZ
North America, California, United States, Menlo Park
Co-Investments: 1
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Ulmus Investment?

MakinaRocks

Seoul, Seoul-t'ukpyolsi, South Korea

MakinaRocks delivers specialized AI solutions that drive enterprise productivity, powered by its industry-leading AI platform.

Enterprise SoftwareMachine LearningSoftware
UndisclosedDec 31, 2024
Amount Raised: $12,000,000
Eul Biosciences

Seocho, Seoul-t'ukpyolsi, South Korea

Eul Biosciences is a biotechnology company that develops regenerative aesthetic cosmetics and wound dressing products.

BiopharmaBiotechnologyLife Science
Series ASep 25, 2024
Amount Raised: $11,297,543
AITRICS

Seocho, Seoul-t'ukpyolsi, South Korea

AITRICS is taking on the ultimate role of giving everyone access to the power of data-driven health intelligence.

AnalyticsArtificial Intelligence (AI)Health CareInformation TechnologySoftware
Series BMar 21, 2024
Amount Raised: $20,299,925